(Total Views: 489)
Posted On: 03/08/2022 7:14:01 AM
Post# of 145880
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: USS JOHNSTON #119656
USS, this is from 2018, he's a cancer researcher....
"Dr. Pestell founded ProstaGene, LLC in 2011 to rapidly bring cancer patients the benefits of novel cancer metastasis therapeutics. ProstaGene is developing technology based on patents in the U.S. and Australia issued to Dr. Pestell for targeting CCR5 in cancer. These patented technologies are built on findings by Dr. Pestell and others that CCR5 is a key target for metastasis in many types of cancer. In his research, Dr. Pestell found that nearly half of tumors in more than 2,200 patients with breast cancer showed overexpression of CCR5. Preclinical studies conducted by Dr. Pestell and published in peer-reviewed journals showed that CCR5 inhibitors dramatically blocked prostate cancer metastasis to the bones and brain of immune competent mice and blocked the spread of breast cancer to the lungs."
https://www.cytodyn.com/investors/news-events...prostagene
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)